ock and independent origins for the cholera pandemic clones. PLoS One 2008;3:e4053.
Hu D, Liu B, Feng L, Ding P, Guo X, Wang M, et al
. Origins of the current seventh cholera pandemic. Proc Natl Acad Sci U S A 2016;113:E7730-9.
Barzilay EJ, Schaad N, Magloire R, Mung KS, Boncy J, Dahourou GA, et al
. Cholera surveillance during the Haiti epidemic-the first 2 years. N
Engl J Med 2013;368:599-609.
Ali M, Nelson AR, Lopez AL, Sack DA. Updated global burden of cholera in endemic countries. PLoS Negl Trop Dis 2015;9:e0003832.
Ali M, Sen Gupta S, Arora N, Khasnobis P, Venkatesh S, Sur D, et al
. Identification of burden hotspots and risk factors for cholera in India: An observational study. PLoS One 2017;12:e0183100.
Letchumanan V, Chan KG, Pusparajah P, Saokaew S, Duangjai A, Goh BH, et al
. Insights into bacteriophage application in controlling Vibrio
species. Front Microbiol 2016;7:1114.
Naser IB, Hoque MM, Abdullah A, Bari SM, Ghosh AN, Faruque SM. Environmental bacteriophages active on biofilms and planktonic forms of toxigenic Vibrio cholerae
: Potential relevance in cholera epidemiology. PLoS One 2017;12:e0180838.
Faruque SM, Naser IB, Islam MJ, Faruque AS, Ghosh AN, Nair GB, et al
. Seasonal epidemics of cholera inversely correlate with the prevalence of environmental cholera phages. Proc Natl Acad Sci U S A 2005;102:1702-7.
Brüssow H, Canchaya C, Hardt WD. Phages and the evolution of bacterial pathogens: From genomic rearrangements to lysogenic conversion. Microbiol Mol Biol Rev 2004;68:560-602.
Hassan F, Kamruzzaman M, Mekalanos JJ, Faruque SM. Satellite phage TLCφ enables toxigenic conversion by CTX phage through dif site alteration. Nature 2010;467:982-5.
Waldor MK, Mekalanos JJ. Lysogenic conversion by a filamentous phage encoding cholera toxin. Science 1996;272:1910-4.
Faruque SM, Mekalanos JJ. Phage-bacterial interactions in the evolution of toxigenic Vibrio cholerae
. Virulence 2012;3:556-65.
Basu S, Mukerjee S. Bacteriophage typing of Vibrio
eltor. Experientia 1968;24:299-300.
Chattopadhyay DJ, Sarkar BL, Ansari MQ, Chakrabarti BK, Roy MK, Ghosh AN, et al
. New phage typing scheme for Vibrio cholerae
O1 biotype El Tor strains. J Clin Microbiol 1993;31:1579-85.
Chakrabarti AK, Ghosh AN, Nair GB, Niyogi SK, Bhattacharya SK, Sarkar BL. Development and evaluation of a phage typing scheme for Vibrio cholerae
O139. J Clin Microbiol 2000;38:44-9.
Sarkar BL, Bhowmick TS, Das M, Rajendran K, Nair GB. Phage types of Vibrio cholerae
O1 and O139 in the past decade in India. Jpn J Infect Dis 2011;64:312-5.
Yen M, Cairns LS, Camilli A. A cocktail of three virulent bacteriophages prevents Vibrio cholerae
infection in animal models. Nat Commun 2017;8:14187.
Bhandare S, Colom J, Baig A, Ritchie JM, Bukhari H, Shah MA, et al
. Reviving phage therapy for the treatment of cholera. J Infect Dis 2019;219:786-94.
Sarkar A, Morita D, Ghosh A, Chowdhury G, Mukhopadhyay AK, Okamoto K, et al
. Altered integrative and conjugative elements (ICEs) in recent Vibrio cholera
O1 isolated from cholera cases, Kolkata, India. Front Microbiol 2019;10:2072.
Gupta PK, Pant ND, Bhandari R, Shrestha P. Cholera outbreak caused by drug resistant Vibrio cholerae
serogroup O1 biotype ElTor serotype Ogawa in Nepal; a cross-sectional study. Antimicrob Resist Infect Control 2016;5:23.
Rijal N, Acharya J, Adhikari S, Upadhaya BP, Shakya G, Kansakar P, et al
. Changing epidemiology and antimicrobial resistance in Vibrio cholerae
: AMR surveillance findings (2006-2016) from Nepal. BMC Infect Dis 2019;19:801.
Uppal B, Mehra B, Panda PS, Kumar SK. Changing epidemiology and antimicrobial resistance pattern of Vibrio cholerae
isolates at a tertiary care health laboratory in North India (2011-2015). Trop J Med Res 2017;20:132-8. [Full text]
Sharma NC, Mandal PK, Dhillon R, Jain M. Changing profile of Vibrio cholerae
O1, O139 in Delhi and its periphery (2003-2005). Indian J Med Res 2007;125:633-40.
] [Full text]
Rashed SM, Hasan NA, Alam M, Sadique A, Sultana M, Hoq MM, et al
. Vibrio cholera
O1 with reduced susceptibility to ciprofloxacin and azithromycin isolated f